EUVIMEDEUVIMED entdecken
Crossref

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine

Charles Khouri iD, Alex Hlavaty iD, Michele Fusaroli iD, Nitin Joshi iD, Francesco Salvo iD, Andrew Bate iD, Antoine Pariente iD, Emanuel Raschi iD

Clinical Pharmacology & Therapeutics · 2026-02 · 119 (2) · 318-321

DOI: 10.1002/cpt.70180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 21.12.2025. Verfasst von Charles Khouri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Evidence-Based Medicine, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, different national and international regulatory authorities, notably the FDA, have made their adverse event repositories publicly available, offering user‐friendly dashboards. This has led to a large increase in low‐quality, poorly reported research using adverse event reporting databases (e.g., FDA’s Adverse Event Reporting System [FAERS]). Such publications producing thousands of statistical associations erroneously presented as “safety signals” can create unscientifically grounded alarm with considerable impact on healthcare provider practices and patient behaviors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAdverse Drug Reaction Reporting SystemsEvidence-Based MedicineDrug-Related Side Effects and Adverse ReactionsHumansUnited StatesUnited States Food and Drug AdministrationDatabases, Factual

Autor:innen und Institutionen

  • Univ. Grenoble Alpes, Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.
  • Univ. Grenoble Alpes, Inserm U1300, HP2, Grenoble, France.
  • Uppsala Monitoring Centre, Uppsala, Sweden.
  • Springer Nature, Auckland, New Zealand.
  • INSERM, BPH, Team AHeaD U1219, Université de Bordeaux, Bordeaux, France.
  • INSERM U1219, CHU de Bordeaux, Service de Pharmacologie Médicale, Bordeaux, France.

ORCID-Profile: Charles Khouri, Alex Hlavaty, Michele Fusaroli, Nitin Joshi, Francesco Salvo, Andrew Bate, Antoine Pariente, Emanuel Raschi

Zitieren

APA

Khouri, C., Hlavaty, A., Fusaroli, M., Joshi, N., Salvo, F., Bate, A., Pariente, A., & Raschi, E. (2026). The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine. Clinical Pharmacology & Therapeutics, 119(2), 318-321. https://doi.org/10.1002/cpt.70180

Vancouver

Khouri C, Hlavaty A, Fusaroli M, Joshi N, Salvo F, Bate A, et al. The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine. Clinical Pharmacology & Therapeutics. 2026;119(2):318-321. doi:10.1002/cpt.70180

BibTeX
@article{Khouri2026,
  author = {Khouri, Charles and Hlavaty, Alex and Fusaroli, Michele and Joshi, Nitin and Salvo, Francesco and Bate, Andrew and Pariente, Antoine and Raschi, Emanuel},
  title = {The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  volume = {119},
  number = {2},
  pages = {318--321},
  doi = {10.1002/cpt.70180}
}
Kostenlos starten →